Autopsy report · NCT03678428

FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM

Cause of deathDrug or device supply Automatic label, confidence 0.9, unverified. How labels are made.

“Production halt of FUDR in China”

The sponsor’s own words in the registry.

Life of this trial

Registered 3 years 3 months before it started.
Ran for about 1 year before it stopped.
92 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 3
Sponsor: Sun Yat-sen University
Sponsor type: University, hospital or other
Conditions: Metastatic Colorectal Cancer; Liver Metastases
Interventions: Irinotecan; Oxaliplatin HAI; Floxuridine; Leucovorin; 5-FU; Oxaliplatin
Participants: 92
Sites: 1
Countries: China

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.